中华普通外科学文献(电子版)
中華普通外科學文獻(電子版)
중화보통외과학문헌(전자판)
CHINESE JOURNAL OF GENERAL SURGERY(ELECTRONIC VERSION)
2014年
4期
298-301
,共4页
胡勇%彭俊平%刘爱祥%张辉%田浪%冯燮林
鬍勇%彭俊平%劉愛祥%張輝%田浪%馮燮林
호용%팽준평%류애상%장휘%전랑%풍섭림
肝癌%不能切除%区域灌注化疗%二步切除
肝癌%不能切除%區域灌註化療%二步切除
간암%불능절제%구역관주화료%이보절제
Hepatocellular cancer%Inoperable%Regional chemoinfusion therapy%Two-stage resection
目的:探讨不能切除肝癌区域灌注化疗后二步切除的必要性及手术指征和手术时机、手术方式。方法回顾性分析2004年2月至2010年9月收治的不能切除的肝癌患者8例,均经肝动脉门静脉双途径区域灌注化疗后获二步切除。结果二步切除距末次灌注化疗时间为20~46(34.5±4.6)d,术前接受化疗3~6(4.2±1.6)个疗程。8例二步切除标本均查见癌细胞,并有较多的纤维组织增生。切除后肿瘤直径平均(5.6±2.3)cm, l、2、3年生存率为87.5%、62.5%、50.0%。结论不能切除肝癌的二步切除是提高中晚期肝癌切除率、延长生存期的有效途径。二步切除手术时机一般以3~6个疗程区域化疗后、末次治疗后1个月左右为宜。
目的:探討不能切除肝癌區域灌註化療後二步切除的必要性及手術指徵和手術時機、手術方式。方法迴顧性分析2004年2月至2010年9月收治的不能切除的肝癌患者8例,均經肝動脈門靜脈雙途徑區域灌註化療後穫二步切除。結果二步切除距末次灌註化療時間為20~46(34.5±4.6)d,術前接受化療3~6(4.2±1.6)箇療程。8例二步切除標本均查見癌細胞,併有較多的纖維組織增生。切除後腫瘤直徑平均(5.6±2.3)cm, l、2、3年生存率為87.5%、62.5%、50.0%。結論不能切除肝癌的二步切除是提高中晚期肝癌切除率、延長生存期的有效途徑。二步切除手術時機一般以3~6箇療程區域化療後、末次治療後1箇月左右為宜。
목적:탐토불능절제간암구역관주화료후이보절제적필요성급수술지정화수술시궤、수술방식。방법회고성분석2004년2월지2010년9월수치적불능절제적간암환자8례,균경간동맥문정맥쌍도경구역관주화료후획이보절제。결과이보절제거말차관주화료시간위20~46(34.5±4.6)d,술전접수화료3~6(4.2±1.6)개료정。8례이보절제표본균사견암세포,병유교다적섬유조직증생。절제후종류직경평균(5.6±2.3)cm, l、2、3년생존솔위87.5%、62.5%、50.0%。결론불능절제간암적이보절제시제고중만기간암절제솔、연장생존기적유효도경。이보절제수술시궤일반이3~6개료정구역화료후、말차치료후1개월좌우위의。
Objective To investigate the necessity, operational indication, operation time and operation details of two-stage resection of inoperable hepatocellular cancer after regional chemoinfusion therapy.Methods From February 2004 to September 2010, eight patients with inoperable hepatocellular cancer accepted two-stage resection after regional chemoinfusion via IDDS(implanted drug-delivery system) in hepatic artery and portal vein.Results All the two-stage resections were schemed 20-46 days (average:34.5±4.6) after the last regional chemoinfusion. Patients received 3-6 preoperative regimens(average:4.2±1.6). Cancer cells were found in all the specimens from 8 patients. The center of tumor was necrotized and became fish-like, yellow brown or dark brown, with thickened pseudo-membrane and focal cancer cells alive near the margin. The average diameter of resected cancer was (5.6±2.3) cm, and the survival rates of 1-, 2-, 3-year were 87.5%, 62.5% and 50.0%.Conclusion The regional chemoinfusion therapy is an effective way to improve the rate of resection and prolong the survival time of advanced hepatocellular cancer. The two-stage resection is schemed after 3-6 regimens of chemotherapy and 1month after the last regimen.